Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has issued an announcement.
Neuroscientific Biopharmaceuticals Ltd announced the application for the quotation of 85,714,264 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, impacting stakeholders by increasing the accessibility of its shares.
More about Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd is a company operating in the biopharmaceutical industry, focusing on the development of neurological therapies. The company is engaged in creating innovative treatments for neurodegenerative conditions.
Average Trading Volume: 428,090
Technical Sentiment Signal: Buy
Current Market Cap: A$13.01M
For an in-depth examination of NSB stock, go to TipRanks’ Overview page.